Stay updated on Pembro and Vorinostat in Stage IV NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page.

Latest updates to the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page
- Check2 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study details, and includes a Home link, indicating the record is temporarily inaccessible.SummaryDifference20%

- Check9 days agoChange DetectedThe page shows Revision: v3.7.0, replacing Revision: v3.6.6, indicating a version update. This update appears to be a page maintenance change rather than a study content modification.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedPage revision updated to v3.6.6, indicating a deployment/refresh of the study page. This reflects a maintenance or metadata update rather than a substantive change to study details or eligibility.SummaryDifference0.1%

- Check44 days agoChange DetectedThe page now displays Revision: v3.6.5 instead of Revision: v3.6.4, indicating a software version update for the site. No study details or content are altered as a result.SummaryDifference0.1%

- Check65 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a minor update to the page's revision history. This change does not alter study data, eligibility criteria, or user-facing content.SummaryDifference0.1%

- Check87 days agoChange DetectedFooter/credits now include the Moffitt Cancer Center Clinical Trials website and the full institutional name, and the site revision is updated from v3.6.0 to v3.6.3.SummaryDifference0.2%

Stay in the know with updates to Pembro and Vorinostat in Stage IV NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro and Vorinostat in Stage IV NSCLC Clinical Trial page.